Health
Moderna skyrockets 11% after receiving additional $472 million of funding, starting Phase 3 trial of COVID-19 vaccine – Business Insider Australia
- Moderna on Sunday announced it received a commitment of up to $US472 million in additional funding from its contract with the Biomedical Advanced Research and Development Authority.
- The company on Monday announced that the Phase 3 trial for its COVID-19 vaccine had started dosing participants.
- Shares of Moderna surged as much as 11% in premarket trading Monday
- Watch Moderna trade live on Markets Insider.
- Read more on Business Insider.
Shares of …
Continue Reading
-
General21 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News20 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General12 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
Noosa News21 hours agoThe Best Things to Do in Brisbane This New Year’s Eve